✉news HealthMedicine first seen 5 d ago, last 5 d ago, peak #37
Artiva to shut down after two trial deaths
Original: After two deaths in autoimmune cell therapy trial, Artiva is shutting down
Biotech company Artiva Biotherapeutics is shutting down following the deaths of two patients enrolled in its cell therapy trial for autoimmune disease. The deaths prompted a halt to the study, leaving the company unable to continue operations. The case has revived debate over safety monitoring in cell therapy trials and the financial fragility of small biotechs whose fortunes hinge on a single clinical program.
Why now: Patient deaths in a cell therapy trial forced a clinical halt and the company's closure, raising safety concerns.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/3937252